VOCLOSPORIN IS EFFECTIVE IN ACHIEVING PROTEINURIA TREATMENT TARGETS IN LUPUS NEPHRITIS DEFINED BY EULAR/ERA RECOMMENDATIONS

被引：1
|
作者：
Anders, H. J. [1 ]
Federico, R. [2 ]
Randhawa, S. [2 ]
Leher, H. [2 ]
机构：
[1] Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany
[2] Aurinia Pharmaceut Inc, Med Affairs, Victoria, BC, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.210
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0285
引用
收藏
页码：189 / 189
页数：1
相关论文
共 50 条
  • [1] Voclosporin Is Effective in Achieving Proteinuria Treatment Targets in Lupus Nephritis Defined by EULAR/ERA Recommendations
    Anders, Hans-Joachim
    Federico, Raymond
    Birardi, Vanessa
    Leher, Henry
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 708 - 710
  • [2] Voclosporin Is Effective in Achieving Complete Renal Response in Severe Lupus Nephritis
    Menn-Josephy, Hanni
    Truman, Matt
    Palmen, Mary
    Mina-Osorio, Paola
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 48 - 48
  • [3] Voclosporin for the treatment of lupus nephritis
    Dolff, Sebastian
    NEPHROLOGIE, 2022, 17 (05): : 334 - 338
  • [4] Voclosporin for the Treatment of Lupus Nephritis
    Cohen, Clemens
    Nitschmann, S.
    INTERNIST, 2021, 62 (10): : 1133 - 1136
  • [5] Treatment of Crescentic Lupus Nephritis with Voclosporin
    Hussain, Irshad
    Bukhari, Syed H.
    Shanley, Paul F.
    Bhargava, Ramya
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 454 - 454
  • [6] Efficacy of Voclosporin in Proliferative Lupus Nephritis with High Levels of Proteinuria
    Menn-Josephy, Hanni
    Hodge, Lucy S.
    Birardi, Vanessa
    Leher, Henry
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (03): : 309 - 318
  • [7] An evaluation of voclosporin for the treatment of lupus nephritis
    Sin, Fang En
    Isenberg, David
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (14) : 1613 - 1621
  • [8] JOINT EULAR/ERA-EDTA RECOMMENDATIONS FOR THE MANAGEMENT OF ADULT AND PEDIATRIC LUPUS NEPHRITIS
    Bertsias, G.
    Tektonidou, M.
    Amoura, Z.
    Aringer, M.
    Bajema, I.
    Berden, J.
    Boletis, J.
    Cervera, R.
    Doerner, T.
    Doria, A.
    Ferrario, F.
    Floege, J.
    Houssiau, F.
    Ioannidis, J. P.
    Isenberg, D.
    Kallenberg, C. G.
    Lightstone, L.
    Marks, S.
    Martini, A.
    Moroni, G.
    Neumann, I.
    Niaudet, P.
    Praga, M.
    Schneider, M.
    Tesar, V.
    Vasconcelos, C.
    van Vollenhoven, R.
    Zakharova, E.
    Haubitz, M.
    Gordon, C.
    Jayne, D.
    Boumpas, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 74 - 75
  • [9] ATTAINMENT OF EULAR/ERA-EDTA TREATMENT TARGETS IN THE FIRST YEAR IN LUPUS NEPHRITIS: A MULTICENTER OBSERVATIONAL STUDY
    Pappa, M.
    Kosmetatou, M.
    Pieta, A.
    Nikoloudaki, M.
    Argyriou, E.
    Tsalapaki, C.
    Chalkia, A.
    Dimitroulas, T.
    Cheila, M.
    Papagoras, C.
    Goules, A.
    Petras, D.
    Vassilopoulos, D.
    Boki, K. A.
    Sfikakis, P.
    Voulgari, P.
    Bertsias, G.
    Boumpas, D.
    Tektonidou, M.
    Fanouriakis, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 907 - 907
  • [10] Voclosporin: A Novel Calcineurin Inhibitor for the Treatment of Lupus Nephritis
    McArn, Ann C.
    Nixon, Alexander R.
    Jarrell, Katherine L.
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (11) : 1267 - 1274
12345